Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Conditions:   Anatomic Stage I Breast Cancer AJCC v8;   Anatomic Stage II Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer AJCC v8;   Early Stage Triple-Negative Breast Carcinoma Interventions:   Procedure: Biospecimen Collection;   Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Docetaxel;   Drug: Doxorubicin;   Drug: Paclitaxel;   Biological: Pembrolizumab;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Procedure: Surgical Proc edure Sponsors:   SWOG Cancer Research Netwo...
Source: ClinicalTrials.gov - July 3, 2023 Category: Research Source Type: clinical trials